Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

Completed · Not applicable

Conditions studied: Endometrial Adenocarcinoma, Endometrial Carcinoma, Lynch Syndrome, Relatives

In brief

This clinical trial studies universal screening for deoxyribonucleic acid (DNA) mismatch repair deficiency in patients with endometrial cancer, mutations in the genes responsible for Lynch syndrome (inherited forms of endometrial cancers) and other DNA changes that could help guide treatment strategies. Universal tumor DNA sequencing may help doctors better understand how to personalize care, increase length of life, and increase quality of life in patients with endometrial cancer and their relatives.

Key facts

Study ID
NCT03460483
Run by
Ohio State University Comprehensive Cancer Center
People needed
1001
Starts
2018-03-30
Expected to finish
2025-06-15
Last updated by the study team
2025-10-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.